| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |